Savard, Peter M.

Publications

Sort by

Co-Author Network

Dose-response and Cardiopulmonary Side Effects of the Novel Neuromuscular-blocking Drug CW002 in Man. Anesthesiology. 2016 Academic Article GET IT
Times cited: 9
Preclinical Pharmacology of CW002: A Nondepolarizing Neuromuscular Blocking Drug of Intermediate Duration, Degraded and Antagonized by l-cysteine-Additional Studies of Safety and Efficacy in the Anesthetized Rhesus Monkey and Cat. Anesthesiology. 2016 Academic Article GET IT
Rapid chemical antagonism of neuromuscular blockade by L-cysteine adduction to and inactivation of the olefinic (double-bonded) isoquinolinium diester compounds gantacurium (AV430A), CW 002, and CW 011. Anesthesiology. 2010 Academic Article GET IT
Times cited: 25
Fumarates: unique nondepolarizing neuromuscular blocking agents that are antagonized by cysteine. Journal of critical care. 2009 Review GET IT
Times cited: 20